查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1865466

照護現場診斷市場預測至2032年：按產品、檢體類型、檢測方法、技術、應用、最終用戶和地區分類的全球分析

Point-of-Care Diagnostics Market Forecasts to 2032 - Global Analysis By Product, Sample Type, Mode of Testing, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球照護現場診斷市場預計將在 2025 年達到 506 億美元，並在 2032 年達到 750 億美元，預測期內複合年成長率為 5.8%。

照護現場診斷是指在患者照護地點或附近進行的醫學檢測，無需中心實驗室即可快速獲得結果。這些檢測旨在提供便利、快速和易用的服務，使醫護人員能夠立即做出臨床決策。常見的應用包括血糖監測、感染疾病檢測、懷孕檢測和心臟標記檢測。即時診斷使用攜帶式設備和易於使用的試劑盒，通常只需極少的培訓即可操作。它們在急診室、診所、偏遠地區和家庭環境中都至關重要。透過縮短檢測結果等待時間並改善患者預後，照護現場診斷在現代分散式醫療服務中發揮關鍵作用。

對快速早期診斷的需求日益成長

對快速早期診斷日益成長的需求是推動照護現場市場發展的主要因素。這些檢測能夠幫助醫護人員即時做出臨床決策，尤其是在急診、農村和居家照護等場景下。隨著感染疾病和慢性病病例的增加，醫療專業人員需要快速、準確的檢測結果才能及時啟動治療。照護現場解決方案能夠縮短結果等待時間，改善患者預後，並支援分散式醫療服務。其便利性和快速性使其成為全球醫療系統中現代醫學不可或缺的工具。

監理和合規挑戰

監管和合規方面的挑戰是照護現場市場面臨的重大阻礙因素。設備必須滿足嚴格的安全、準確性和品質標準，而這些標準因地區而異，這可能會延遲產品核可和市場准入。複雜的法規結構要求在測試、文件編制和認證方面投入大量資金。這些障礙尤其給Start-Ups和中小型製造商帶來了沉重的負擔。此外，不斷變化的資料隱私和診斷準確性法規也進一步加劇了合規工作的複雜性。

技術進步

技術進步為市場成長提供了強勁機會。生物感測器、微流體和攜帶式分析儀的創新正在提升檢測速度、準確性和易用性。與數位平台和行動應用程式的整合實現了即時數據共用和遠端監控。這些創新為個人化醫療、遠端醫療和分散式醫療模式提供了支援。隨著對使用者友善診斷工具的需求日益成長，科技主導的解決方案正在改變醫療服務模式。持續的研發投入可望開拓新的應用領域，並提高已開發市場和新興市場的醫療服務可近性。

成本和報銷問題

成本和報銷問題對照護現場市場構成重大威脅。設備和耗材的高昂前期成本會阻礙其普及，尤其是在資源匱乏的地區。各地不同的報銷政策為醫療機構和製造商帶來不確定性。由於缺乏明確的保險覆蓋範圍，患者需要自費，這可能會限制他們獲得必要的診斷服務。這些經濟障礙阻礙了市場擴張和創新。解決價格承受能力問題並建立支持性的報銷機制對於確保即時診斷技術的廣泛應用至關重要。

新冠疫情的影響：

新冠疫情顯著加速了照護現場技術的應用。對快速檢測和分散式醫療解決方案的迫切需求凸顯了攜帶式、易用型診斷工具的價值。即時檢測在篩檢、監測和疫情控制中發揮了關鍵作用，尤其是在偏遠和高風險地區。此次危機也推動了生物感測器和移動診斷技術的創新，進而重塑了公共衛生策略。隨著醫療系統適應後疫情時代的新常態，照護現場系統的韌性、提升應對能力並促進以患者為中心的醫療服務。

預計在預測期內，生物感測器細分市場將佔據最大的市場佔有率。

由於生物感測器在實現快速、準確的照護現場方面發揮關鍵作用，預計在預測期內，生物感測器領域將佔據最大的市場佔有率。生物感測器能夠即時檢測生物標記物，支援感染疾病檢測、血糖監測和心臟診斷等應用。將其整合到攜帶式設備中，提高了便利性和可及性。隨著對快速可靠診斷的需求不斷成長，生物感測器始終處於創新前沿。靈敏度、小型化和連接性的持續進步將進一步鞏固其在即時診斷領域的領先地位。

預計在預測期內，糖尿病細分市場將實現最高的複合年成長率。

預計在預測期內，糖尿病領域將實現最高成長率，這主要得益於全球糖尿病盛行率的不斷上升以及對持續血糖監測的需求。照護現場技術能夠提供便利的即時血糖檢測，幫助患者有效管理自體病情。生物感測器和穿戴式裝置的進步正在提升檢測的準確性和易用性。隨著醫療保健系統將慢性病管理置於優先地位，對便利、個人化的糖尿病診斷的需求持續成長。該領域的快速成長反映了其在預防和長期照護中的重要作用。

佔比最大的地區：

由於醫療保健需求不斷成長、中產階級人口不斷壯大以及各國政府為改善醫療保健服務可及性而採取的舉措，預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家正在投資建造分散式醫療保健基礎設施和提供價格合理的診斷解決方案。該地區強大的製造業基礎和行動醫療技術的日益普及將進一步推動市場擴張。亞太地區充滿活力的醫療保健環境使其成為照護現場技術創新和應用領域的領導者。

複合年成長率最高的地區：

在預測期內，北美預計將實現最高的複合年成長率，這主要得益於其先進的醫療基礎設施、強勁的研發投入以及對快速診斷的旺盛需求。該地區對個人化醫療、遠端醫療和慢性病管理的重視，推動了即時診斷（POC）技術的廣泛應用。監管支持和報銷系統也促進了創新和市場准入。北美擁有許多主要製造商和早期採用者，預計將繼續引領照護現場的技術進步和市場成長。

免費客製化服務：

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要參與者（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，提供主要國家的市場估算和預測以及複合年成長率（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要參與者的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球照護現場（依產品分類）

  • 血糖監測套件
  • 傳染病檢查試劑盒
  • 懷孕與不孕症檢測套組
  • 心臟代謝監測套件
  • 血液檢測套組
  • 血液凝固檢驗盒
  • 尿液檢查試劑盒
  • 藥物濫用檢測套組
  • 癌症/腫瘤標記檢測套組
  • 其他產品

6. 全球照護現場診斷市場（依檢體類型分類）

  • 血
  • 尿
  • 唾液
  • 鼻咽拭子
  • 其他樣本類型

7. 全球照護現場診斷市場（依檢測方法分類）

  • 處方箋測試
  • 非處方藥 (OTC) 檢測

8. 全球照護現場（依技術分類）

  • 側向流動法
  • 油尺
  • 微流體
  • 分子診斷
  • 免疫檢測
  • 生物感測器
  • 其他技術

9. 全球照護現場診斷市場（按應用分類）

  • 感染疾病
  • 糖尿病
  • 心血管疾病
  • 癌症
  • 懷孕和生育能力
  • 呼吸系統疾病
  • 其他應用

第10章 全球照護現場診斷市場（以最終用戶分類）

  • 醫院及加護治療中心
  • 診所和醫生辦公室
  • 居家照護機構
  • 門診治療環境
  • 診斷實驗室
  • 研究和學術機構

第11章 全球照護現場診斷市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Danaher Corporation
  • Becton, Dickinson and Company（BD）
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific
  • bioMerieux SA
  • Bio-Rad Laboratories
  • Hologic, Inc.
  • LumiraDx Ltd.
  • SD Biosensor
  • Nova Biomedical Corporation
  • Trinity Biotech plc
  • Werfen
Product Code: SMRC32117

According to Stratistics MRC, the Global Point-of-Care Diagnostics Market is accounted for $50.6 billion in 2025 and is expected to reach $75.0 billion by 2032 growing at a CAGR of 5.8% during the forecast period. Point-of-care diagnostics refers to medical testing conducted at or near the site of patient care, providing rapid results without the need for centralized laboratory facilities. These tests are designed for convenience, speed, and accessibility, enabling healthcare providers to make immediate clinical decisions. Common applications include glucose monitoring, infectious disease detection, pregnancy testing, and cardiac markers. POC diagnostics utilize portable devices and easy-to-use kits, often requiring minimal training. They are essential in emergency rooms, clinics, remote areas, and home settings. By reducing turnaround time and improving patient outcomes, point-of-care diagnostics play a vital role in modern, decentralized healthcare delivery.

Market Dynamics:

Driver:

Growing Demand for Rapid and Early Diagnosis

The increasing need for rapid and early diagnosis is a major driver of the point-of-care diagnostics market. These tests enable immediate clinical decisions, especially in emergency settings, rural areas, and home care. With rising cases of infectious and chronic diseases, healthcare providers rely on fast, accurate results to initiate timely treatment. Point-of-care solutions reduce turnaround time, improve patient outcomes, and support decentralized healthcare delivery. Their convenience and speed make them indispensable tools in modern medical practice across global health systems.

Restraint:

Regulatory and Compliance Challenges

Regulatory and compliance challenges pose a significant restraint to the point-of-care diagnostics market. Devices must meet stringent safety, accuracy, and quality standards across different regions, which can delay product approvals and market entry. Navigating complex regulatory frameworks requires substantial investment in testing, documentation, and certification. These hurdles are especially burdensome for startups and small manufacturers. Additionally, evolving regulations around data privacy and diagnostic accuracy further complicate compliance.

Opportunity:

Advancements in technology

Technological advancements offer a powerful opportunity for growth in the market. Innovations in biosensors, microfluidics, and portable analyzers are enhancing test speed, accuracy, and usability. Integration with digital platforms and mobile apps enables real-time data sharing and remote monitoring. These breakthroughs support personalized medicine, telehealth, and decentralized care models. As demand for user-friendly diagnostic tools rises, technology-driven solutions are transforming healthcare delivery. Continued R&D investment will unlock new applications and improve accessibility in both developed and emerging markets.

Threat:

Cost and Reimbursement Issues

Cost and reimbursement issues represent a key threat to the point-of-care diagnostics market. High upfront costs for devices and consumables can deter adoption, especially in low-resource settings. Inconsistent reimbursement policies across regions create uncertainty for providers and manufacturers. Without clear coverage, patients may face out-of-pocket expenses, limiting access to essential diagnostics. These financial barriers hinder market expansion and innovation. Addressing affordability and establishing supportive reimbursement frameworks are critical to ensuring widespread adoption.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of point-of-care diagnostics. The urgent need for rapid testing and decentralized healthcare solutions highlighted the value of portable, easy-to-use diagnostic tools. POC tests played a crucial role in screening, monitoring, and managing outbreaks, especially in remote and high-risk areas. The crisis also spurred innovation in biosensors and mobile diagnostics, reshaping public health strategies. As healthcare systems adapt to post-pandemic realities, point-of-care diagnostics continue to support resilience, preparedness, and patient-centered care across global markets.

The biosensors segment is expected to be the largest during the forecast period

The biosensors segment is expected to account for the largest market share during the forecast period, due to its central role in enabling rapid, accurate point-of-care testing. Biosensors detect biological markers in real time, supporting applications in infectious disease detection, glucose monitoring, and cardiac diagnostics. Their integration into portable devices enhances usability and accessibility. As demand for fast, reliable diagnostics grows, biosensors remain at the forefront of innovation. Continued advancements in sensitivity, miniaturization, and connectivity will further solidify their dominance in the POC diagnostics landscape.

The diabetes segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diabetes segment is predicted to witness the highest growth rate, due to global rise in diabetes prevalence and the need for continuous glucose monitoring. Point-of-care diagnostics offer convenient, real-time blood sugar testing, empowering patients to manage their condition effectively. Advances in biosensors and wearable devices are enhancing accuracy and ease of use. As healthcare systems prioritize chronic disease management, demand for accessible, personalized diabetes diagnostics continues to surge. This segment's rapid growth reflects its critical role in preventive and long-term care.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising healthcare demand, expanding middle-class populations, and government initiatives to improve medical access. Countries like China, India, and Japan are investing in decentralized healthcare infrastructure and affordable diagnostic solutions. The region's strong manufacturing base and increasing adoption of mobile health technologies further support market expansion. Asia Pacific's dynamic healthcare landscape positions it as a leader in point-of-care innovation and deployment.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure, strong R&D investment, and high demand for rapid diagnostics. The region's focus on personalized medicine, telehealth, and chronic disease management supports widespread adoption of POC technologies. Regulatory support and reimbursement frameworks also encourage innovation and market entry. With leading manufacturers and early adopters, North America continues to set the pace for technological advancement and market growth in point-of-care diagnostics.

Key players in the market

Some of the key players in Point-of-Care Diagnostics Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Becton, Dickinson and Company (BD), QuidelOrtho Corporation, Thermo Fisher Scientific, bioMerieux SA, Bio-Rad Laboratories, Hologic, Inc., LumiraDx Ltd., SD Biosensor, Nova Biomedical Corporation, Trinity Biotech plc, and Werfen.

Key Developments:

In June 2025, Abbott and MSD Pharmaceuticals (Merck & Co.) have forged a strategic distribution partnership in India for MSD's oral anti-diabetic drugs Sitagliptin, its fixed-dose combination with metformin and the extended-release version marketed under the names Januvia, Janumet and Janumet XR.

In March 2025, Cadrenal Therapeutics and Abbott have entered collaboration for the "TECH-LVAD" trial to evaluate Tecarfarin in patients using the HeartMate 3 left ventricular assist device (LVAD).

Products Covered:

  • Glucose Monitoring Kits
  • Infectious Disease Testing Kits
  • Pregnancy and Fertility Testing Kits
  • Cardiometabolic Monitoring Kits
  • Hematology Testing Kits
  • Coagulation Testing Kits
  • Urinalysis Testing Kits
  • Drug-of-Abuse Testing Kits
  • Cancer/Tumor Markers Testing Kits
  • Other Products

Sample Types Covered:

  • Blood
  • Urine
  • Saliva
  • Nasal/Throat Swabs
  • Other Sample Types

Modes of Testing Covered:

  • Prescription-Based Testing
  • Over-the-Counter (OTC) Testing

Technologies Covered:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Biosensors
  • Other Technologies

Applications Covered:

  • Infectious Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Cancer
  • Pregnancy and Fertility
  • Respiratory Diseases
  • Other Applications

End Users Covered:

  • Hospitals and Critical Care Centers
  • Clinics and Physician Offices
  • Home Care Settings
  • Ambulatory Care Settings
  • Diagnostic Laboratories
  • Research and Academic Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Point-of-Care Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Glucose Monitoring Kits
  • 5.3 Infectious Disease Testing Kits
  • 5.4 Pregnancy and Fertility Testing Kits
  • 5.5 Cardiometabolic Monitoring Kits
  • 5.6 Hematology Testing Kits
  • 5.7 Coagulation Testing Kits
  • 5.8 Urinalysis Testing Kits
  • 5.9 Drug-of-Abuse Testing Kits
  • 5.10 Cancer/Tumor Markers Testing Kits
  • 5.11 Other Products

6 Global Point-of-Care Diagnostics Market, By Sample Type

  • 6.1 Introduction
  • 6.2 Blood
  • 6.3 Urine
  • 6.4 Saliva
  • 6.5 Nasal/Throat Swabs
  • 6.6 Other Sample Types

7 Global Point-of-Care Diagnostics Market, By Mode of Testing

  • 7.1 Introduction
  • 7.2 Prescription-Based Testing
  • 7.3 Over-the-Counter (OTC) Testing

8 Global Point-of-Care Diagnostics Market, By Technology

  • 8.1 Introduction
  • 8.2 Lateral Flow Assays
  • 8.3 Dipsticks
  • 8.4 Microfluidics
  • 8.5 Molecular Diagnostics
  • 8.6 Immunoassays
  • 8.7 Biosensors
  • 8.8 Other Technologies

9 Global Point-of-Care Diagnostics Market, By Application

  • 9.1 Introduction
  • 9.2 Infectious Diseases
  • 9.3 Diabetes
  • 9.4 Cardiovascular Diseases
  • 9.5 Cancer
  • 9.6 Pregnancy and Fertility
  • 9.7 Respiratory Diseases
  • 9.8 Other Applications

10 Global Point-of-Care Diagnostics Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals and Critical Care Centers
  • 10.3 Clinics and Physician Offices
  • 10.4 Home Care Settings
  • 10.5 Ambulatory Care Settings
  • 10.6 Diagnostic Laboratories
  • 10.7 Research and Academic Institutes

11 Global Point-of-Care Diagnostics Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 F. Hoffmann-La Roche Ltd.
  • 13.3 Siemens Healthineers
  • 13.4 Danaher Corporation
  • 13.5 Becton, Dickinson and Company (BD)
  • 13.6 QuidelOrtho Corporation
  • 13.7 Thermo Fisher Scientific
  • 13.8 bioMerieux SA
  • 13.9 Bio-Rad Laboratories
  • 13.10 Hologic, Inc.
  • 13.11 LumiraDx Ltd.
  • 13.12 SD Biosensor
  • 13.13 Nova Biomedical Corporation
  • 13.14 Trinity Biotech plc
  • 13.15 Werfen

List of Tables

  • Table 1 Global Point-of-Care Diagnostics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Point-of-Care Diagnostics Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Point-of-Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2024-2032) ($MN)
  • Table 4 Global Point-of-Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2024-2032) ($MN)
  • Table 5 Global Point-of-Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2024-2032) ($MN)
  • Table 6 Global Point-of-Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2024-2032) ($MN)
  • Table 7 Global Point-of-Care Diagnostics Market Outlook, By Hematology Testing Kits (2024-2032) ($MN)
  • Table 8 Global Point-of-Care Diagnostics Market Outlook, By Coagulation Testing Kits (2024-2032) ($MN)
  • Table 9 Global Point-of-Care Diagnostics Market Outlook, By Urinalysis Testing Kits (2024-2032) ($MN)
  • Table 10 Global Point-of-Care Diagnostics Market Outlook, By Drug-of-Abuse Testing Kits (2024-2032) ($MN)
  • Table 11 Global Point-of-Care Diagnostics Market Outlook, By Cancer/Tumor Markers Testing Kits (2024-2032) ($MN)
  • Table 12 Global Point-of-Care Diagnostics Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 13 Global Point-of-Care Diagnostics Market Outlook, By Sample Type (2024-2032) ($MN)
  • Table 14 Global Point-of-Care Diagnostics Market Outlook, By Blood (2024-2032) ($MN)
  • Table 15 Global Point-of-Care Diagnostics Market Outlook, By Urine (2024-2032) ($MN)
  • Table 16 Global Point-of-Care Diagnostics Market Outlook, By Saliva (2024-2032) ($MN)
  • Table 17 Global Point-of-Care Diagnostics Market Outlook, By Nasal/Throat Swabs (2024-2032) ($MN)
  • Table 18 Global Point-of-Care Diagnostics Market Outlook, By Other Sample Types (2024-2032) ($MN)
  • Table 19 Global Point-of-Care Diagnostics Market Outlook, By Mode of Testing (2024-2032) ($MN)
  • Table 20 Global Point-of-Care Diagnostics Market Outlook, By Prescription-Based Testing (2024-2032) ($MN)
  • Table 21 Global Point-of-Care Diagnostics Market Outlook, By Over-the-Counter (OTC) Testing (2024-2032) ($MN)
  • Table 22 Global Point-of-Care Diagnostics Market Outlook, By Technology (2024-2032) ($MN)
  • Table 23 Global Point-of-Care Diagnostics Market Outlook, By Lateral Flow Assays (2024-2032) ($MN)
  • Table 24 Global Point-of-Care Diagnostics Market Outlook, By Dipsticks (2024-2032) ($MN)
  • Table 25 Global Point-of-Care Diagnostics Market Outlook, By Microfluidics (2024-2032) ($MN)
  • Table 26 Global Point-of-Care Diagnostics Market Outlook, By Molecular Diagnostics (2024-2032) ($MN)
  • Table 27 Global Point-of-Care Diagnostics Market Outlook, By Immunoassays (2024-2032) ($MN)
  • Table 28 Global Point-of-Care Diagnostics Market Outlook, By Biosensors (2024-2032) ($MN)
  • Table 29 Global Point-of-Care Diagnostics Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 30 Global Point-of-Care Diagnostics Market Outlook, By Application (2024-2032) ($MN)
  • Table 31 Global Point-of-Care Diagnostics Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 32 Global Point-of-Care Diagnostics Market Outlook, By Diabetes (2024-2032) ($MN)
  • Table 33 Global Point-of-Care Diagnostics Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
  • Table 34 Global Point-of-Care Diagnostics Market Outlook, By Cancer (2024-2032) ($MN)
  • Table 35 Global Point-of-Care Diagnostics Market Outlook, By Pregnancy and Fertility (2024-2032) ($MN)
  • Table 36 Global Point-of-Care Diagnostics Market Outlook, By Respiratory Diseases (2024-2032) ($MN)
  • Table 37 Global Point-of-Care Diagnostics Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 38 Global Point-of-Care Diagnostics Market Outlook, By End User (2024-2032) ($MN)
  • Table 39 Global Point-of-Care Diagnostics Market Outlook, By Hospitals and Critical Care Centers (2024-2032) ($MN)
  • Table 40 Global Point-of-Care Diagnostics Market Outlook, By Clinics and Physician Offices (2024-2032) ($MN)
  • Table 41 Global Point-of-Care Diagnostics Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 42 Global Point-of-Care Diagnostics Market Outlook, By Ambulatory Care Settings (2024-2032) ($MN)
  • Table 43 Global Point-of-Care Diagnostics Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 44 Global Point-of-Care Diagnostics Market Outlook, By Research and Academic Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.